Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 233
Selected: 0
NCT IDTitle
NCT05886933Study to Evaluate the Efficacy and Safety of FEXUCLUE Tablet
NCT05614778Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosis
NCT02952547Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects
NCT02241850Genetic Polymorphisms Affecting Effect of High Intensity Training
NCT03512808A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fasting Conditions
NCT04772443Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507
NCT01654640The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine
NCT03811080Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease
NCT06000657Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir
NCT06647888Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia
NCT05832697An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers
NCT04221399Type 2 Diabetes Patients With Renal Impairment
NCT05378360DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities
NCT05109702A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry Eye
NCT03184415Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis
NCT06354127DWP450 for Treating Moderate to Severe Glabellar Lines
NCT01945684A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity
NCT03947528Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions
NCT05389215Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
NCT07096921The Effect of Two Prokinetics in Patients With Functional Dyspepsia
NCT06671392A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension
NCT03184402Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)
NCT04613895Treatment Effect According to Timing of Administration of DWP14012 40 mg
NCT04159961Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers
NCT02369302Pharmacokinetics and Drug Interaction Study Between DWC20141 and DWC20142 in Healthy Male Volunteers
NCT03517319Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity
NCT03753477Clinical Trial to Investigate the Efficacy and Safety of DWJ1351
NCT06062030Efficacy and Safety of DWJ1609 for Bowel Cleansing Before Colonoscopy;
NCT06866509To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients
NCT05192395A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers
NCT02622685A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects
NCT05813561The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis
NCT06109259Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1567 in Healthy Adult Volunteers
NCT06119958Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects
NCT01634308Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation
NCT05737771To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination
NCT07190391Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe Psoriasis
NCT05304845Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects
NCT01764295Clinical Study for Patients With Hypertension Associated With Dyslipidemia
NCT04926623Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2)
NCT06212960Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines
NCT01635686Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers
NCT03016520Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers
NCT04185805Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (III)
NCT04767815To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers
NCT05414591Pharmacokinetics and Safety Following Administration of DWP16001
NCT03369990DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy
NCT02947620Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)
NCT01552954Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan
NCT07746518Efficacy and Safety of DWP14012 for Long-Term Maintenance Therapy in Patients With Healed Erosive Esophagitis